Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mersi Pharmaceuticals is a Turkish pharmaceutical company specializing in the development, manufacturing, and marketing of high-quality pharmaceutical products. The company maintains a strong focus on ophthalmology, offering a comprehensive portfolio of treatments for conditions such as glaucoma, ocular hypertension, and allergic conjunctivitis. Beyond eye care, Mersi operates in therapeutic areas including the central nervous system (CNS), internal medicine, and dermatology. The company operates a state-of-the-art manufacturing facility in Istanbul and is committed to providing affordable healthcare solutions through both generic and innovative product offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mersi Pharmaceuticals.